Pharma Archives - Life Sciences Times

Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement

July 5, 2022

BioMed Realty Announces Landmark Lease with Takeda at 585 Kendall to Accommodate Cambridge Expansion

June 22, 2022

MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science

June 15, 2022

Colliers Advises Vibalogics in 118,000-SF Life Science Deal in Boxborough

November 13, 2020

New England Biolabs Leases 28,000 SF

December 7, 2020

Boston Properties Announces 138,000 Square Foot, 10-Year Lease With Translate Bio in Waltham, Massachusetts

November 10, 2020

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®

Virpax Pursues OTC Medical Device Pathway for AnQlar™

Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies

Kite’s CAR T-cell Therapy Yescarta® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma

Virpax Will Pursue Direct to OTC Pathway for Epoladerm™ for Pain Associated with Osteoarthritis

Most Read

New 12-month Results from RHINTRAC Randomized Controlled Trial Demonstrate Durable Safety and Efficacy of Aerin Medical’s RhinAer® for Treatment of Chronic Rhinitis

Gnubiotics Sciences Announces Funding from the Swiss Innovation Agency to Accelerate Development of Glycopeptide Mediated Immunotherapies against Solid Tumors

Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity

Proteintech Group Inc. opens new Singapore office

EDITOR PICKS